Z & N Healthcare Limited iXBRL

Z & N Healthcare Limited

Director's Report and Unaudited Financial Statements

for the financial year ended 31 December 2024

Z & N Healthcare Limited

DIRECTOR AND OTHER INFORMATION


Director	Mr Mustafa Sayed


Company Secretary	Ms Nadia Sayed


Company Registration Number	08808244


Registered Office and Business Address	61 St. Thomas Street,
	Weymouth
	Dorset
	DT4 8EQ
	United Kingdom


Accountants	A Hunter & Co
	61 St. Thomas Street,
	Weymouth
	DT4 8EQ
	GB

Z & N Healthcare Limited

DIRECTOR'S REPORT

for the financial year ended 31 December 2024

The director presents his report and the unaudited financial statements for the financial year ended 31 December 2024.

Director

The director who served during the financial year is as follows:

Mr Mustafa Sayed

There were no changes in shareholdings between 31 December 2024 and the date of signing the financial statements.

In accordance with the Constitution, the director retire by rotation and, being eligible, offer themselves for re-election.

Political Contributions

The company did not make any disclosable political donations in the current financial year.

Statement of Director's Responsibilities

The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the director is required to:

■

select suitable accounting policies and apply them consistently;

■

make judgements and accounting estimates that are reasonable and prudent;

■

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

Mr Mustafa Sayed

Director

25 September 2025

Z & N Healthcare Limited

PROFIT AND LOSS ACCOUNT

for the financial year ended 31 December 2024

	2024	2023
Notes	£	£

Turnover	57,092	94,604
	─────────	─────────
Gross profit	57,092	94,604

Administrative expenses	(59,892)	(56,371)
	─────────	─────────
Operating (loss)/profit	(2,800)	38,233

Interest payable and similar expenses	(392)	-
	─────────	─────────
(Loss)/profit before taxation	(3,192)	38,233

Tax on (loss)/profit	-	(7,264)
	─────────	─────────
(Loss)/profit for the financial year	(3,192)	30,969
	─────────	─────────
Total comprehensive income	(3,192)	30,969
	═════════	═════════

Z & N Healthcare Limited

Company Registration Number: 08808244

BALANCE SHEET

as at 31 December 2024

		2024	2023
	Notes	£	£

Current Assets

Debtors

5,403

5,707

Cash and cash equivalents

1,753

4,498

─────────

7,156

10,205

─────────

Creditors: amounts falling due within one year

(10,239)

(10,096)

─────────

Net Current (Liabilities)/Assets

(3,083)

109

─────────

Total Assets less Current Liabilities

(3,083)

109

═════════

Capital and Reserves

Called up share capital

100

100

Retained earnings

(3,183)

─────────

Equity attributable to owners of the company

(3,083)

109

═════════

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Director and authorised for issue on 25 September 2025



________________________________
Mr Mustafa Sayed
Director

Z & N Healthcare Limited

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 December 2024

General Information

Z & N Healthcare Limited is a company limited by shares incorporated and registered in England. The registered number of the company is 08808244. The registered office of the company is 61 St. Thomas Street,, Weymouth, Dorset, DT4 8EQ, United Kingdom which is also the principal place of business of the company. Health Activities The financial statements have been presented in Pound (£) which is also the functional currency of the company.

Summary of Significant Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

Statement of compliance

The financial statements of the company for the financial year ended 31 December 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

Turnover

Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Employee benefits

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.

Taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.

Ordinary share capital

The ordinary share capital of the company is presented as equity.

Employees

The average monthly number of employees, including director, during the financial year was 2, (2023 - 2).

2024

2023

Number

Number

Management

═════════


4.	Debtors	2024	2023
		£	£

	Other debtors	-	1,440
	Director's current account	-	4,267
	Taxation (Note 6)	5,403	-
		─────────	─────────
		5,403	5,707
		═════════	═════════


5.	Creditors	2024	2023
	Amounts falling due within one year	£	£

	Taxation (Note 6)	-	8,956
	Director's current account	9,039	-
	Accruals	1,200	1,140
		─────────	─────────
		10,239	10,096
		═════════	═════════


6.	Taxation	2024	2023
		£	£

	Debtors:
	PAYE / NI	5,403	-
		═════════	═════════
	Creditors:
	Corporation tax	-	8,704
	PAYE / NI	-	252
		─────────	─────────
		-	8,956
		═════════	═════════

Capital commitments

The company had no material capital commitments at the financial year-ended 31 December 2024.

Post-Balance Sheet Events

There have been no significant events affecting the company since the financial year-end.